Skip navigation

Calls to Action

new medicines for autism

Autism Tops Reuters List of European Innovative Medicine Programs

September 15, 2014

(Sept. 15, 2014) Thomson Reuters Research Analytics has rated EU-AIMS – the autism research program of the European Innovative Medicines Initiative (IMI) – as the initiative’s best-performing area. The rating is based on the number and quality of scientific papers coming out of the program.

Can Translational Neuroscience Deliver Effective Treatments for Autism?

IMFAR keynote speaker identifies barriers to delivering better treatments and how international collaboration can break the logjam
May 15, 2014

Neurodevelopmental psychiatrist Declan Murphy, of King’s College London, delivered the first keynote address of the 2014 International Meeting for Autism Research (IMFAR) today in Atlanta.